Tissue engineering and regenerative medicine involve many different artificial and biologic
materials, frequently integrated in composite scaffolds, which can be repopulated with …

Surgically bypassing or replacing a severely damaged artery using a biodegradable
synthetic vascular graft is a promising treatment that allows for the remodeling and …

Natural blood vessels have completed functions, including elasticity, compliance, and
excellent antithrombotic properties because of their mature structure. To replace damaged …

Last twenties, tissue engineering has rapidly advanced to address the shortage of organ
donors. Decellularization techniques have been developed to mitigate immune rejection …

Cell‐free polymeric tissue‐engineered vascular grafts (TEVGs) have shown great promise
towards clinical translation; however, their limited bioactivity and remodeling ability …

To treat coronary heart disease, coronary artery bypass grafts are used to divert blood flow
around blockages in the coronary arteries. Autologous grafts are the gold standard of care …

The gold standard vascular substitutes, used in cardiovascular surgery, are the Dacron or
expanded polytetrafluoroethylene (ePTFE)-derived grafts. However, major adverse …

Vascular tissue engineering is a promising approach for regenerating damaged blood
vessels and developing new therapeutic approaches for heart disease treatment. To date …

Tissue-engineered vascular grafts (TEVGs) are considered one of the most effective means
of fabricating vascular grafts. However, for small-diameter TEVGs, there are ongoing issues …

Small diameter (< 6 mm) vessel grafts still pose a challenge for scientists worldwide.
Decellularised umbilical artery (dUA) remains promising as small diameter tissue …